Sanara MedTech (SMTI) Competitors $25.84 +0.19 (+0.74%) As of 10:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMTI vs. MDXG, INMD, SSII, KMTS, IRMD, SIBN, SMLR, EMBC, CBLL, and BVSShould you be buying Sanara MedTech stock or one of its competitors? The main competitors of Sanara MedTech include MiMedx Group (MDXG), InMode (INMD), SS Innovations International (SSII), Kestra Medical Technologies (KMTS), iRadimed (IRMD), SiBone (SIBN), Semler Scientific (SMLR), Embecta (EMBC), CeriBell (CBLL), and Bioventus (BVS). These companies are all part of the "medical equipment" industry. Sanara MedTech vs. Its Competitors MiMedx Group InMode SS Innovations International Kestra Medical Technologies iRadimed SiBone Semler Scientific Embecta CeriBell Bioventus Sanara MedTech (NASDAQ:SMTI) and MiMedx Group (NASDAQ:MDXG) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment and earnings. Which has preferable valuation and earnings, SMTI or MDXG? MiMedx Group has higher revenue and earnings than Sanara MedTech. Sanara MedTech is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$86.67M2.65-$9.66M-$1.34-19.28MiMedx Group$348.88M2.83$42.42M$0.2724.80 Do analysts prefer SMTI or MDXG? Sanara MedTech currently has a consensus target price of $49.50, indicating a potential upside of 91.56%. MiMedx Group has a consensus target price of $11.50, indicating a potential upside of 71.77%. Given Sanara MedTech's higher probable upside, equities analysts plainly believe Sanara MedTech is more favorable than MiMedx Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00MiMedx Group 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is SMTI or MDXG more profitable? MiMedx Group has a net margin of 11.40% compared to Sanara MedTech's net margin of -12.48%. MiMedx Group's return on equity of 22.70% beat Sanara MedTech's return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-12.48% -29.22% -13.20% MiMedx Group 11.40%22.70%16.77% Does the media favor SMTI or MDXG? In the previous week, MiMedx Group had 2 more articles in the media than Sanara MedTech. MarketBeat recorded 3 mentions for MiMedx Group and 1 mentions for Sanara MedTech. Sanara MedTech's average media sentiment score of 0.94 beat MiMedx Group's score of 0.37 indicating that Sanara MedTech is being referred to more favorably in the media. Company Overall Sentiment Sanara MedTech Positive MiMedx Group Neutral Which has more volatility & risk, SMTI or MDXG? Sanara MedTech has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.76, suggesting that its share price is 76% more volatile than the S&P 500. Do institutionals and insiders have more ownership in SMTI or MDXG? 8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 79.2% of MiMedx Group shares are held by institutional investors. 42.6% of Sanara MedTech shares are held by insiders. Comparatively, 1.7% of MiMedx Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryMiMedx Group beats Sanara MedTech on 11 of the 14 factors compared between the two stocks. Get Sanara MedTech News Delivered to You Automatically Sign up to receive the latest news and ratings for SMTI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMTI vs. The Competition Export to ExcelMetricSanara MedTechMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$229.72M$10.38B$5.71B$9.50BDividend YieldN/A2.00%4.60%3.99%P/E Ratio-19.2816.9627.8819.97Price / Sales2.6526.86452.35101.58Price / CashN/A23.2136.5558.97Price / Book5.813.648.635.89Net Income-$9.66M$234.77M$3.24B$258.50M7 Day Performance-1.79%5.23%3.90%2.07%1 Month Performance-7.94%7.15%10.47%12.39%1 Year Performance-19.73%-14.37%34.29%19.25% Sanara MedTech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMTISanara MedTech1.6853 of 5 stars$25.84+0.7%$49.50+91.6%-17.8%$229.72M$86.67M-19.2860Positive NewsMDXGMiMedx Group3.4359 of 5 stars$6.80+2.1%$12.50+83.8%-7.2%$1.00B$348.88M25.19870Upcoming EarningsINMDInMode3.7863 of 5 stars$14.74+0.2%$18.54+25.8%-17.9%$931.70M$392.41M6.33480Upcoming EarningsSSIISS Innovations InternationalN/A$4.75-4.8%N/AN/A$919.60M$20.65M0.004Gap DownKMTSKestra Medical TechnologiesN/A$15.43+3.5%$27.50+78.2%N/A$792.32M$52.64M0.00300IRMDiRadimed4.9269 of 5 stars$58.07+0.9%$72.00+24.0%+18.0%$738.65M$73.24M37.46110Positive NewsUpcoming EarningsGap DownSIBNSiBone4.0725 of 5 stars$17.32+0.7%$22.50+29.9%+5.7%$738.18M$167.18M-27.06350News CoverageSMLRSemler Scientific2.6432 of 5 stars$45.23-0.7%$89.00+96.8%+18.1%$619.20M$56.29M-17.33120EMBCEmbecta4.6843 of 5 stars$10.37-1.0%$19.33+86.4%-30.4%$606.05M$1.08B11.522,100CBLLCeriBell2.3806 of 5 stars$16.38+1.5%$32.14+96.2%N/A$591.97M$65.44M0.00N/ABVSBioventus3.3652 of 5 stars$6.81-2.3%$13.75+101.9%-14.2%$559.40M$567.70M-11.161,200 Related Companies and Tools Related Companies MiMedx Group Competitors InMode Competitors SS Innovations International Competitors Kestra Medical Technologies Competitors iRadimed Competitors SiBone Competitors Semler Scientific Competitors Embecta Competitors CeriBell Competitors Bioventus Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMTI) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanara MedTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanara MedTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
